HUAWEI Sence G1 is the company's first continuous glucose monitor

HUAWEI enters the glucose monitoring market

HUAWEI has revealed its first continuous glucose monitor, the Sence G1, in a post on Weibo, according to Android Authority. The device is a small sensor worn on the body that tracks blood sugar levels around the clock, a category of product mainly used by people with diabetes.

The announcement marks a step beyond the company's existing wearables, which so far have consisted of smartwatches and fitness bands, including models that measure blood pressure. HUAWEI says the Sence G1 is its first product to hold a Class III medical device classification, the strictest regulatory tier in China.

How the Sence G1 works

The monitor does not work in isolation. Glucose readings can be viewed on a HUAWEI phone, smartwatch or fitness band, and the sensor also warns the wearer when levels spike or dip unusually.

Based on images shared with the announcement, the sensor is roughly the size of a coin and is designed to be worn on the upper arm. HUAWEI has not said how long each sensor lasts before it needs replacing, nor has it disclosed a price.

Some performance figures come from earlier leaks rather than the company itself. Android Authority reports that the Chinese outlet IT Home previously cited a lag time of 5 to 15 minutes and a mean absolute relative difference, a standard accuracy measure for glucose sensors, of under 10%. These figures remain unconfirmed by HUAWEI.

A long road to certification

Development of the Sence G1 has taken years. Bruce Lee, a HUAWEI vice president, said in a separate post that the company first tried the product three years ago, in December 2023, and that teams working on it have worn it for considerably longer. He described it as one of the products the company has taken the longest to master.

The slow timeline likely reflects the regulatory bar. According to a report by VCBeat cited by Android Authority, China's National Medical Products Administration approved the device on 30 October 2026. Class III approval is a demanding process, which helps explain why HUAWEI kept quiet about the project until now.

Who can use it, and will it leave China?

HUAWEI has not announced pricing, availability or a launch date. The company has only confirmed the product exists and that it has Chinese regulatory approval.

A global launch looks uncertain. Android Authority notes that because the monitor depends on other HUAWEI products to display readings, the company may limit it to markets where its phone and wearable ecosystem is strong. HUAWEI's international smartphone business was sharply reduced by US sanctions during the first Trump administration, but the company remains a leading player in China.

For now, the Sence G1 matters mainly as a sign of HUAWEI's ambitions in health hardware. Continuous glucose monitors are a growing category, and a major wearable maker entering it with a certified device could bring more competition and more choice for users in China.